Instagram may become the social medium of choice for pharma marketers now that it has been purchased by Face-book and has added several new features that allow marketers to potentially thwart FDA regulations.
This article summarizes various scenarios for how the FDA, courts, and independent 3rd-parties may influence off-label drug promotion in the future.
Welcome to Vol. 15, Issue No. 1 (JANUARY 2016) of Pharma Marketing News. New Drug Approvals, FDA Enforcement Actions, 2016 New Year's Resolution, and Digitally Savvy Women Pharma Pioneers are the themes of this issue.
This article summarizes several comments submitted to the FDA in response to the agency's proposed study of animation in direct-to-consumer drug ads.
This article summarizes the First Amendment assault on FDA's ability to regulate off-label communications.
This article is a review of the e-book entitled Pharma 3D: Rewriting the script for marketing in the digital age.
This article describes how Boehringer Ingelheim teamed up with with Univison in a ground-breaking campaign to drive awareness for Type 2 Diabetes through story-line integrations in the original production, Bajo el Mismo Cielo (Under the Same Sky).
Trying to determine what portion of pharma's total marketing budget is devoted to digital and if that portion is increasing, is a daunting task.
Welcome to Vol. 15, Issue No. 2 (MARCH 2016) of Pharma Marketing News. TV DTC, ad mascots, Off-label promotion.
The big jump in DTC advertising & high cost of drugs have resulted in calls for a total ban of DTC advertising or the elimination of tax deductions for DTC advertising. And the FDA is planning a bevy of studies, which may lead to new guidelines.